Literature DB >> 30788626

Psychosocial distress in oncology: using the distress thermometer for assessing risk classes.

Claudia Cormio1, Francesca Caporale2, Roberta Spatuzzi3, Fulvia Lagattolla2, Andrea Lisi2, Giusi Graziano2.   

Abstract

PURPOSE: Cancer patients often suffer for psychological distress, which can compromise their quality of life. Our study aimed to recognize risk classes for the development of psychosocial distress.
METHODS: Three hundred seventy-two adult cancer patients were assessed by the Distress Thermometer (DT) and Problem List at the National Cancer Research Centre "Giovanni Paolo II" of Bari. We also compiled a socio-medical and clinical-medical record survey ad hoc for collecting socio-demographic information and clinical variables. To examine the interplay among the different variables and distinguish internally homogeneous subgroups of patients with diverse risks of distress, the RECursive Partitioning and Amalgamation (RECPAM) technique was used.
RESULTS: Most of patients were female and the most frequent diagnosis was breast cancer, followed by gastro-intestinal cancer and hematological cancer. Distress was present in 43% of the sample, with a total of 156 patients with a DT > 5. The RECPAM analysis identified three distinct and homogeneous patient subgroups (RECPAM classes) with different risks of distress: diagnosis, marital status, and Eastern Cooperative Oncology Group Performance Status.
CONCLUSION: The use of the distress thermometer allows clinicians to identify patients with certain characteristics that may increase the risk of developing psychosocial distress. This evaluation can allow timely psychological intervention and improve the patient's therapeutic program.

Entities:  

Keywords:  Cancer; Distress; Distress thermometer; RECPAM; Risk class

Mesh:

Year:  2019        PMID: 30788626     DOI: 10.1007/s00520-019-04694-4

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  30 in total

1.  Emotional distress: the sixth vital sign--future directions in cancer care.

Authors:  Barry D Bultz; Linda E Carlson
Journal:  Psychooncology       Date:  2006-02       Impact factor: 3.894

Review 2.  [Prevalence of affective and anxiety disorders in cancer: systematic literature review and meta-analysis].

Authors:  Sigrun Vehling; Uwe Koch; Natalie Ladehoff; Gerhard Schön; Karl Wegscheider; Ulrike Heckl; Joachim Weis; Anja Mehnert
Journal:  Psychother Psychosom Med Psychol       Date:  2012-05-14

3.  Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study.

Authors:  A J Roth; A B Kornblith; L Batel-Copel; E Peabody; H I Scher; J C Holland
Journal:  Cancer       Date:  1998-05-15       Impact factor: 6.860

4.  Screening for psychologic distress in ambulatory cancer patients.

Authors:  Paul B Jacobsen; Kristine A Donovan; Peter C Trask; Stewart B Fleishman; James Zabora; Frank Baker; Jimmie C Holland
Journal:  Cancer       Date:  2005-04-01       Impact factor: 6.860

Review 5.  Illness representations, coping, and illness outcomes in people with cancer: a systematic review and meta-analysis.

Authors:  Emma M Richardson; Natalie Schüz; Kristy Sanderson; Jennifer L Scott; Benjamin Schüz
Journal:  Psychooncology       Date:  2016-08-21       Impact factor: 3.894

6.  Adherence to hormone therapy in women with breast cancer: a quantitative study.

Authors:  Laura Iacorossi; Francesca Gambalunga; Alessandra Fabi; Diana Giannarelli; Gabriella Facchinetti; Michela Piredda; Maria Grazia De Marinis
Journal:  Prof Inferm       Date:  2016 Apr-Jun

Review 7.  Screening for distress and depression in cancer settings: 10 lessons from 40 years of primary-care research.

Authors:  Alex J Mitchell; Arshya Vahabzadeh; Kathryn Magruder
Journal:  Psychooncology       Date:  2011-03-27       Impact factor: 3.894

8.  Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Authors:  M M Oken; R H Creech; D C Tormey; J Horton; T E Davis; E T McFadden; P P Carbone
Journal:  Am J Clin Oncol       Date:  1982-12       Impact factor: 2.339

9.  The prevalence of psychological distress by cancer site.

Authors:  J Zabora; K BrintzenhofeSzoc; B Curbow; C Hooker; S Piantadosi
Journal:  Psychooncology       Date:  2001 Jan-Feb       Impact factor: 3.894

10.  The measure of psychological distress in cancer patients: the use of Distress Thermometer in the Oncological Rehabilitation Center of Florence.

Authors:  Francesco Bulli; Guido Miccinesi; Alice Maruelli; Manuel Katz; Eugenio Paci
Journal:  Support Care Cancer       Date:  2008-12-03       Impact factor: 3.603

View more
  3 in total

1.  Effects of the Heart to Heart Card Game for Patients with Advanced Cancer Receiving Home-Based Palliative Care: A Clinical Randomized Controlled Trial.

Authors:  Jiayi Du; Ling Fu; Jiaxin Cui; Zifen An; Pei Fang; Lanhui Tan; Xianmei Meng; Liping Yu
Journal:  Int J Environ Res Public Health       Date:  2022-05-17       Impact factor: 4.614

Review 2.  Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group.

Authors:  Samantha J Mayo; Maryam Lustberg; Haryana M Dhillon; Zev M Nakamura; Deborah H Allen; Diane Von Ah; Michelle C Janelsins; Alexandre Chan; Karin Olson; Chia Jie Tan; Yi Long Toh; Jeong Oh; Lisa Grech; Yin Ting Cheung; Ishwaria Mohan Subbiah; Duska Petranovic; James D'Olimpio; Margherita Gobbo; Susanne Koeppen; Charles L Loprinzi; Linda Pang; Shivani Shinde; Olanipekun Ntukidem; Katherine B Peters
Journal:  Support Care Cancer       Date:  2020-11-24       Impact factor: 3.603

3.  The Head and Neck Survivorship Tool (HN-STAR) Trial (WF-1805CD): A protocol for a cluster-randomized, hybrid effectiveness-implementation, pragmatic trial to improve the follow-up care of head and neck cancer survivors.

Authors:  Talya Salz; Jamie S Ostroff; Chandylen L Nightingale; Thomas M Atkinson; Eleanor C Davidson; Sankeerth R Jinna; Anuja Kriplani; Glenn J Lesser; Kathleen A Lynch; Deborah K Mayer; Kevin C Oeffinger; Sujata Patil; Andrew L Salner; Kathryn E Weaver
Journal:  Contemp Clin Trials       Date:  2021-05-21       Impact factor: 2.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.